Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development
- PMID: 2065891
- DOI: 10.1096/fasebj.5.10.2065891
Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development
Abstract
Recent analysis of primate lentivirus genomes indicates that lentiviruses have infected primates for hundreds of years. The pathogenicity of such viruses may fluctuate due to the high evolution rate of some parts of the viral genome. Fixed nucleic acid substitutions in the gag gene appear to be caused by random fixation of selectively neutral mutants, whereas nonrandom fixation of selectively advantageous mutants, as has been observed for MHC molecules and serine protease inhibitors, appears to be operational for some hypervariable env gene regions. The former is characterized by an excess of silent mutations independent of the rate of change, the latter by an excess of nonsilent mutations. This latter type of selection may especially characterize the third variable region of the external HIV envelope (V3), which contains the principal neutralization domain.
Similar articles
-
Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution.Virology. 1991 Nov;185(1):195-205. doi: 10.1016/0042-6822(91)90767-6. Virology. 1991. PMID: 1656585
-
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).AIDS Res Hum Retroviruses. 1994 Sep;10(9):1143-55. doi: 10.1089/aid.1994.10.1143. AIDS Res Hum Retroviruses. 1994. PMID: 7826699
-
Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10527-31. doi: 10.1073/pnas.89.21.10527. Proc Natl Acad Sci U S A. 1992. PMID: 1438241 Free PMC article.
-
Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.Chem Immunol. 1993;56:1-33. Chem Immunol. 1993. PMID: 8383980 Review. No abstract available.
-
Immunobiology of the human immunodeficiency virus envelope and its relationship to vaccine strategies.Mol Biol Med. 1990 Feb;7(1):1-15. Mol Biol Med. 1990. PMID: 2182967 Review.
Cited by
-
Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6325-9. doi: 10.1073/pnas.90.13.6325. Proc Natl Acad Sci U S A. 1993. PMID: 8327513 Free PMC article.
-
Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.Vaccines (Basel). 2020 Oct 8;8(4):591. doi: 10.3390/vaccines8040591. Vaccines (Basel). 2020. PMID: 33050053 Free PMC article.
-
The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.Immunology. 1995 Jun;85(2):176-83. Immunology. 1995. PMID: 7642208 Free PMC article.
-
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function.J Virol. 1997 Mar;71(3):1871-9. doi: 10.1128/JVI.71.3.1871-1879.1997. J Virol. 1997. PMID: 9032317 Free PMC article.
-
Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.Neuropsychol Rev. 2017 Jun;27(2):101-123. doi: 10.1007/s11065-017-9348-2. Epub 2017 May 24. Neuropsychol Rev. 2017. PMID: 28536861 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials